Gliotenzide 10 / 20

Array
(
    [ID] => 1223
    [post_author] => 16
    [post_date] => 2012-06-18 19:14:45
    [post_date_gmt] => 2012-06-18 19:14:45
    [post_content] => 
Forma farmacéutica:
Comprimidos
Composición:
Cada comprimido contiene:
Gliotenzide 10: Enalapril Maleato 10 mg, Hidroclorotiazida: 25 mg
Gliotenzide 20: Enalapril Maleato 20 mg, Hidroclorotiazida: 12,5 mg
Acción Terapéutica:
Antihipertensivo, Asociación de un inhibidor de la enzima convertidora de angiotensina (ECA) y un diurético.
Indicaciones:
Tratamiento de la hipertensión en pacientes en los que es apropiada la terapia combinada.
Presentaciones:
Gliotenzide 10: Envases por 30 comprimidos.
Gliotenzide 20: Envases por 30 comprimidos.
    [post_title] => Gliotenzide 10 / 20
    [post_excerpt] => Antihipertensivo. Diurético.
    [post_status] => publish
    [comment_status] => closed
    [ping_status] => closed
    [post_password] => 
    [post_name] => gliotenzide
    [to_ping] => 
    [pinged] => 
    [post_modified] => 2024-11-29 12:58:38
    [post_modified_gmt] => 2024-11-29 15:58:38
    [post_content_filtered] => 
    [post_parent] => 0
    [guid] => https://www.bago.com.ar/vademecum//?post_type=productos&p=1223
    [menu_order] => 0
    [post_type] => productos
    [post_mime_type] => 
    [comment_count] => 0
    [filter] => raw
    [prospecto_para_pacientes] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19777
                    [post_author] => 16
                    [post_date] => 2024-11-29 12:57:33
                    [post_date_gmt] => 2024-11-29 15:57:33
                    [post_content] => 
                    [post_title] => GLIOTENZIDE Información paciente Disp. 9592-19
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => gliotenzide-informacion-paciente-disp-9592-19
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-29 12:57:33
                    [post_modified_gmt] => 2024-11-29 15:57:33
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/11/GLIOTENZIDE-Informacion-paciente-Disp.-9592-19.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [url_para_mayor_informacion_video] => 
    [url_para_mayor_informacion] => 
    [url_productos_consumo_masivo] => 
    [prospecto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 19778
                    [post_author] => 16
                    [post_date] => 2024-11-29 12:57:37
                    [post_date_gmt] => 2024-11-29 15:57:37
                    [post_content] => 
                    [post_title] => GLIOTENZIDE Prospecto Disp. 9592-19
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => gliotenzide-prospecto-disp-9592-19
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2024-11-29 12:57:37
                    [post_modified_gmt] => 2024-11-29 15:57:37
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => http://www.bago.com.ar/vademecum/wp-content/uploads/2024/11/GLIOTENZIDE-Prospecto-Disp.-9592-19.pdf
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => application/pdf
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [presentacion_img] => Array
        (
        )

    [logo_img] => Array
        (
        )

    [foto_producto] => Array
        (
            [0] => WP_Post Object
                (
                    [ID] => 13295
                    [post_author] => 16
                    [post_date] => 2017-07-11 11:30:54
                    [post_date_gmt] => 2017-07-11 14:30:54
                    [post_content] => 
                    [post_title] => GLIOTENZIDE-10-20
                    [post_excerpt] => 
                    [post_status] => inherit
                    [comment_status] => open
                    [ping_status] => closed
                    [post_password] => 
                    [post_name] => gliotenzide-10-20-2
                    [to_ping] => 
                    [pinged] => 
                    [post_modified] => 2017-07-11 11:30:54
                    [post_modified_gmt] => 2017-07-11 14:30:54
                    [post_content_filtered] => 
                    [post_parent] => 0
                    [guid] => https://www.bago.com.ar/vademecum/wp-content/uploads/2017/07/GLIOTENZIDE-10-20.png
                    [menu_order] => 0
                    [post_type] => attachment
                    [post_mime_type] => image/png
                    [comment_count] => 0
                    [filter] => raw
                )

        )

    [fotos_lanzamiento] => Array
        (
        )

    [especialidad] => Array
        (
        )

    [marca] => Array
        (
            [0] => Gliotenzide
        )

    [principio_activo] => Array
        (
            [0] => Enalapril
            [1] => Hidroclorotiazida
        )

    [post_content_formatted] => 
Forma farmacéutica:
Comprimidos
Composición:
Cada comprimido contiene:

Gliotenzide 10: Enalapril Maleato 10 mg, Hidroclorotiazida: 25 mg

Gliotenzide 20: Enalapril Maleato 20 mg, Hidroclorotiazida: 12,5 mg
Acción Terapéutica:
Antihipertensivo, Asociación de un inhibidor de la enzima convertidora de angiotensina (ECA) y un diurético.
Indicaciones:
Tratamiento de la hipertensión en pacientes en los que es apropiada la terapia combinada.
Presentaciones:
Gliotenzide 10: Envases por 30 comprimidos.

Gliotenzide 20: Envases por 30 comprimidos.

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => prospectos/GLIOTENZIDE-Prospecto-Disp.-9592-19.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:10257856;}
        )

)

Array
(
    [_wp_attached_file] => Array
        (
            [0] => 2024/11/GLIOTENZIDE-Informacion-paciente-Disp.-9592-19.pdf
        )

    [_wp_attachment_metadata] => Array
        (
            [0] => a:1:{s:8:"filesize";i:2498810;}
        )

)

anexo_congre_single